164 related articles for article (PubMed ID: 32569862)
1. Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers.
Wang L; He Y; He T; Liu G; Lin C; Li K; Lu L; Cai K
Biomaterials; 2020 Oct; 255():120208. PubMed ID: 32569862
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma.
Ren S; Wang Q; Zhang Y; Song Y; Dong X; Zhang W; Qin X; Liu M; Yu T
Int Immunopharmacol; 2018 Nov; 64():69-77. PubMed ID: 30149266
[TBL] [Abstract][Full Text] [Related]
3. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
[TBL] [Abstract][Full Text] [Related]
4. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
[TBL] [Abstract][Full Text] [Related]
5. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
[TBL] [Abstract][Full Text] [Related]
6. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
7. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
[TBL] [Abstract][Full Text] [Related]
8. Proton-Gradient-Driven Porphyrin-Based Liposome Remote-Loaded with Imiquimod as In Situ Nanoadjuvants for Synergistically Augmented Tumor Photoimmunotherapy.
Liu D; Fu L; Gong L; Li S; Li K; Liu K; Yang D
ACS Appl Mater Interfaces; 2024 Feb; 16(7):8403-8416. PubMed ID: 38334116
[TBL] [Abstract][Full Text] [Related]
9. Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response.
Wan D; Que H; Chen L; Lan T; Hong W; He C; Yang J; Wei Y; Wei X
Nano Lett; 2021 Oct; 21(19):7960-7969. PubMed ID: 34533963
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery.
Thomsen LL; Topley P; Daly MG; Brett SJ; Tite JP
Vaccine; 2004 Apr; 22(13-14):1799-809. PubMed ID: 15068864
[TBL] [Abstract][Full Text] [Related]
11. pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation.
Nuhn L; Vanparijs N; De Beuckelaer A; Lybaert L; Verstraete G; Deswarte K; Lienenklaus S; Shukla NM; Salyer AC; Lambrecht BN; Grooten J; David SA; De Koker S; De Geest BG
Proc Natl Acad Sci U S A; 2016 Jul; 113(29):8098-103. PubMed ID: 27382168
[TBL] [Abstract][Full Text] [Related]
12. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.
Zeng Q; Jiang H; Wang T; Zhang Z; Gong T; Sun X
J Control Release; 2015 Feb; 200():1-12. PubMed ID: 25540903
[TBL] [Abstract][Full Text] [Related]
13. Immunoadjuvant-Modified
Niu MT; Chen QW; Chen Z; Liu X; Huang QX; Liang JL; Zhong Z; Cheng H; Zhang XZ
Nano Lett; 2024 Jan; 24(1):130-139. PubMed ID: 38150297
[TBL] [Abstract][Full Text] [Related]
14. Polydopamine-Based Multifunctional Platform for Combined Photothermal Therapy, Chemotherapy, and Immunotherapy in Malignant Tumor Treatment.
Chen R; Zhu C; Fan Y; Feng W; Wang J; Shang E; Zhou Q; Chen Z
ACS Appl Bio Mater; 2019 Feb; 2(2):874-883. PubMed ID: 35016291
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound improved immune adjuvant delivery to induce DC maturation and T cell activation.
Wang X; Shi Z; Luo J; Zeng Y; He L; Chen L; Yao J; Zhang T; Huang P
J Control Release; 2022 Sep; 349():18-31. PubMed ID: 35780954
[TBL] [Abstract][Full Text] [Related]
16. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
[TBL] [Abstract][Full Text] [Related]
17. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
[TBL] [Abstract][Full Text] [Related]
18. Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.
Li C; Zhang X; Chen Q; Zhang J; Li W; Hu H; Zhao X; Qiao M; Chen D
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2874-2889. PubMed ID: 29285934
[TBL] [Abstract][Full Text] [Related]
19. Study on combination therapy for lung cancer through pemetrexed-loaded mesoporous polydopamine nanoparticles.
Xu J; Xu W; Wang Z; Jiang Y
J Biomed Mater Res A; 2023 Feb; 111(2):158-169. PubMed ID: 36479812
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
